- Jefferson Medical College, Philadelphia
Internship / Residency
- University of Pennsylvania Health System, Philadelphia
- Radiology - Thomas Jefferson University Hospital, Philadelphia
- Diagnostic Radiology; Vascular & Interventional Radiology - American Board of Radiology
- Cardiovascular & Interventional Radiology - Thomas Jefferson University Hospital
A firm believer in the Cancer Treatment Centers of America® (CTCA) Mother Standard® of care and the benefits of comprehensive cancer care, Dr. Steven Wagner states, “I approach caring for each patient as if they were my family member. I ask myself what I would do if this were my wife, my father, my mother, my siblings.”
In his role as interventional radiologist at CTCA® in Philadelphia, Dr. Wagner is continually inspired by the determination of his patients.
In 2011, 2012, 2013, 2014, 2015, 2016, and 2017, Dr. Wagner was recognized as a Philadelphia Magazine Top Docs™ award winner in Interventional Radiology. He is board certified in diagnostic radiology and vascular and interventional radiology. His areas of expertise include interventional oncology, peripheral arterial disease, venous disease and musculoskeletal, gastrointestinal and pulmonary interventions, and a variety of interventional cancer therapies.
Dr. Wagner earned a bachelor’s degree from Ursinus College in Collegeville, Pennsylvania, where he graduated summa cum laude with the title of Valedictorian. He then earned a medical degree from Jefferson Medical College in Philadelphia, where he again graduated summa cum laude. During medical school, Dr. Wagner earned multiple honors, including the Humanism in Medicine award granted by the Healthcare Foundation of New Jersey and the Philip J. Hodes Prize in Radiology.
A Pennsylvania native, Dr. Wagner stayed in Philadelphia, where he completed an internship at the University of Pennsylvania Health System, followed by a radiology residency and a cardiovascular and interventional radiology fellowship at Thomas Jefferson University Hospital. During these years, the Radiologic Society of North America honored him with multiple research awards in radiology.
Before coming to CTCA, Dr. Wagner held several positions in hospitals and private practices in and around the Philadelphia area including Doylestown Hospital and Parlee & Tatem Radiologic Associates.
Over the course of his career, Dr. Wagner has authored articles in the Journal of Vascular and Interventional Radiology, the Journal of the Pennsylvania Academy of Sciences, Radiology and the Journal of Computer Assisted Tomography, as well as a book chapter in Abrams’ Angiography. He has also delivered several lectures nationally.
Dr. Wagner describes his reason for joining CTCA: “I decided to join CTCA because I was attracted to the combination of providing highly advanced care and procedures in a truly multidisciplinary setting. After visiting [the hospital], I was impressed by the positive attitude and hope which echoed throughout CTCA.”
At CTCA, Dr. Wagner continually learns new techniques and advancements in medicine that can help his patients.He provides therapies such as SIRSphere®, TheraSphere®, chemoembolization, microwave ablation, radiofrequency ablation, vertebroplasty and NanoKnife®, an ablation technology designed to destroy tumors. Dr. Wagner also performs liver-directed therapies for metastatic and primary liver tumors.
According to Dr. Wagner, “CTCA is one of few institutions to currently offer lung radiofrequency ablation.” He adds, “Furthermore, we are one of only a few institutions in the country to offer coblation for painful spine tumors. I am also delighted about our developing TheraSphere program.”
Dr. Wagner is a member of eight professional organizations, including the Society of Interventional Radiology, American College of Phlebology, American Society of Laser Medicine and Surgery and the American College of Radiology. He credits his wife and three young children for providing him daily encouragement and support.
Patient ratings and comments
Star ratings and comments are only available for medical, radiation and gynecologic oncologists. Gynecologic surgical offerings are not included at this time due to a different survey tool required to evaluate these services. CTCA uses a validated Press Ganey® survey, which captures patient experience feedback for the primary oncology services of chemotherapy and radiation therapy. Following industry best practice, star ratings and comments are only published for physicians with a minimum of 30 completed patient surveys.